EEE Pharma
↗Maharashtra, India
EEE Pharma (also known as EEE Pharmaceuticals) is a pharmaceutical company primarily engaged in the manufacturing and distribution of generic medicines with a strong focus on emerging markets, particularly in Africa. The company specializes in niche therapeutic segments, providing affordable treatment options for chronic and infectious diseases. Its operations are characterized by a robust export model, supplying essential medicines to various African nations including Cameroon, Nigeria, and Ethiopia.
The company maintains manufacturing facilities in Maharashtra, India, which are WHO-GMP certified. These facilities are equipped to produce a wide range of dosage forms, including tablets, capsules, ointments, and dry powders. EEE Pharma emphasizes its research and development capabilities, focusing on formulation development and reverse engineering to create high-quality generic alternatives for regulated and semi-regulated markets.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic Drug Manufacturing
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:1984
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Generic formulations
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Ministry of Health (Cameroon), NAFDAC (Nigeria), Pharmacy and Poisons Board (Kenya), FDA (Ghana)
COMPETITION
Position:Niche Player
Competitors:Cipla, Sun Pharmaceutical Industries, Aurobindo Pharma, Local African pharmaceutical distributors
LINKS
Website:eee.cm
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EEE Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.